The big players of the biopharma world descend on San Francisco next week for the annual JP Morgan Healthcare Conference, and in advance of it, Boston-based PureTech is announcing it has raised $50 million in new funding. PureTech takes successful research out of academic labs, and assembles teams that can move it toward commercialization. Among its projects are startup companies focused on obesity, hair growth, drug delivery without needles, and therapeutic video games. Read More